Transcatheter aortic valve implantation (TAVi)

Clinical evidence

The Medtronic CoreValve™/Evolut™ platform is supported by a robust body of clinical evidence.

Explore the CoreValve™/Evolut™ clinical success.

Comprehensive clinical evidence

Stay up to date on the latest clinical evidence from Medtronic. Key summaries demonstrate the efficacy of the CoreValve™/Evolut™ TAVI platform.

Real-world results

The CoreValve™/Evolut™ platform provides reproducible results from clinical trial to the real world.  

Explore our STS/ACC TVT Registry™* data that supports the excellent clinical performance seen in our trials.

EXPAND TAVI II Pivotal Trial

The purpose of the EXPAND TAVI II Pivotal Trial is to explore the treatment of moderate aortic stenosis (AS) with early aortic valve implantation (AVI) before AS becomes severe, leading to preservation of cardiac function, prevention of further deterioration in cardiac function, and prevention of death in some patients.

Connect with us on social.

Twitter: @medtroniceu 

LinkedIn: Medtronic Cardiac and Vascular

Clinical Evidence Compendium.

A robust body of clinical evidence on the Evolut™ TAVI platform.

Stay informed.

Sign up to get the latest information and resources from Medtronic on treating aortic stenosis and the Evolut™ platform.


™Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.